Anges Medical Chairman Proposes 35-70 Million Yuan Share Buyback Using IPO Funds
Anges Medical Technology Co., Ltd. announced on September 23, 2026, that its chairman and controlling shareholder Zhang Cheng proposed a share buyback of 35-70 million yuan using IPO over-raised funds. The repurchased shares would be used for employee stock ownership plans or equity incentives. The proposal is subject to board approval and remains uncertain.
Editorial responsibility
- No named human review is recorded for this page.
- Reports are grouped by semantic similarity and deterministic rules. Language models may assist titles, summaries, translation and cross-source analysis; the page reads the event directly, while its address stays stable when the title changes.
- Summary covers the current reports
Cross-source coverage
Reporting timeline
Anges Medical's Chairman Proposes Share Buyback Worth 35-70 Million Yuan
On September 23, 2026, Anges Medical Technology Co., Ltd. announced that its board received a proposal from actual controller, chairman, and general manager Zhang Cheng to repurchase company shares. Zhang Cheng proposed using over-raised funds from the company's initial public offering to buy back A-shares via centralized竞价 trading on the Shanghai Stock Exchange. The buyback price will not exceed 150% of the average trading price in the 30 trading days before board approval. The total repurchase amount is set between 35 million yuan and 70 million yuan, with a 12-month period from board approval. Repurchased shares will be used for employee stock ownership plans or equity incentives. Zhang Cheng reported no share transactions in the six months prior and has no current plans to buy or sell during the buyback period. He committed to pushing for board approval and voting in favor. The board deemed the proposal feasible and will develop a specific plan. The implementation is subject to formal board approval and remains uncertain.
Read sourceAnges: Controlling Shareholder Proposes 35-70 Million Yuan Share Buyback
Anges (stock code: 688581) announced on September 23 that its actual controller, chairman and general manager Zhang Cheng, has proposed a share buyback program totaling between 35 million yuan and 70 million yuan. The buyback is intended to fund employee stock ownership plans or equity incentives. The proposal, reported by People's Financial Information on the same day, reflects the company's initiative to align employee interests with shareholder value. The exact timing and execution details of the buyback remain subject to board approval and market conditions.
Read sourceAnges Medical's Controlling Shareholder Zhang Cheng Proposes Share Buyback of 35-70 Million Yuan
On September 23, Anges Medical Science Technology Co., Ltd. announced that its controlling shareholder, Zhang Cheng, has proposed a share buyback plan. The proposal suggests using the company's over-raised funds from its initial public offering to repurchase its A-shares via centralized竞价 trading on the Shanghai Stock Exchange. The buyback price would not exceed 150% of the average trading price in the 30 trading days before the board approves the plan. The total repurchase amount is set between 35 million yuan (inclusive) and 70 million yuan (inclusive), with a completion period of 12 months from board approval. The repurchased shares are intended for employee stock ownership plans or equity incentives. Zhang Cheng stated he had not traded company shares in the six months prior to the proposal and has no current plans to increase or decrease his holdings during the buyback period. He committed to voting in favor of the proposal at the board meeting. The company's board deemed the proposal feasible and will work on a specific plan, subject to board approval. The announcement noted that the plan is uncertain until formal procedures are completed. The article is sourced from Shanghai Securities News and includes a disclaimer that it is AI-generated and not investment advice.
Read sourceShow 2 older updatesHide older updates
Anges proposes 35-70 million yuan share buyback using IPO over-raised funds
Anges (安杰思) announced that its actual controller, chairman and general manager Zhang Cheng proposed on September 22, 2026, that the company repurchase its own shares using over-raised funds from its initial public offering (IPO) of RMB ordinary shares. The total buyback amount is set at no less than RMB 35 million and no more than RMB 70 million. The repurchase price will not exceed 150% of the average trading price of the company's shares in the 30 trading days before the board considers the buyback plan. The repurchased shares are intended for use in an employee stock ownership plan or equity incentive plan. The proposal is subject to board approval.
Anges Medical's controlling shareholder proposes 35-70 million yuan share buyback
Anges Medical Science Technology Co., Ltd. announced that its actual controller, Zhang Cheng, has proposed a share buyback plan. The proposal suggests using the company's over-raised funds from its initial public offering of RMB ordinary shares to repurchase company shares. The total buyback amount is set at no less than 35 million yuan and no more than 70 million yuan. The announcement was reported by Shanghai Securities News via China Securities Network, citing a letter from Zhang Cheng to the company's board. The buyback is intended to be funded by the company's IPO over-raised capital.
Read source